Results 21 to 30 of about 333,288 (246)

Aripiprazole-induced hyperprolactinemia in a young female with delusional disorder

Indian Journal of Psychological Medicine, 2016
Hyperprolactinemia is a common adverse effect of antipsychotic medication. Switching over to aripiprazole or adjunctive aripiprazole has been advocated for optimal management of antipsychotic-induced hyperprolactinemia.
Sam Padamadan Joseph
doaj   +1 more source

Enhancement in dopamine reduces generous behaviour in women.

PLoS ONE, 2019
Generosity is a human behavior common in social contexts. However, humans are not equally generous to everyone alike. Instead, generosity decreases as a function of social distance, an effect called social discounting.
Sergio Oroz Artigas, Lu Liu, Sabrina Strang, Caroline Burrasch, Astrid Hermsteiner, Thomas F Münte, Soyoung Q Park   +6 more
doaj   +1 more source

Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor

Frontiers in Pharmacology, 2022
Nicotine induces kinetic tremor, which resembles pharmacological features of essential tremors, via activating the inferior olive (IO) neurons. Since nicotine is known to enhance dopamine release by stimulating α4β2 and/or α6 nACh receptors, we examined ...
Masaki Kato, Naofumi Kunisawa, Saki Shimizu, Higor A. Iha, Yukihiro Ohno   +4 more
doaj   +1 more source

In a Rush to Decide: Deep Brain Stimulation and Dopamine Agonist Therapy in Parkinson's Disease

Journal of Parkinson’s Disease, 2014
Background: It has been suggested that all patients with Parkinson's disease (PD) who undergo functional neurosurgery have difficulties in slowing down in high conflict tasks.
Atbin Djamshidian, Sean S. O'Sullivan, Alessandro Tomassini, Thomas Foltynie, Patricia Limousin, Iciar Aviles-Olmos, Thomas T. Warner, Andrew J. Lees, Bruno B. Averbeck   +8 more
doaj   +1 more source

Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D₃/D₄ Receptors

Marine Drugs, 2019
The G protein-coupled receptor (GPCR) family of proteins comprises signaling proteins that mediate cellular responses to various hormones and neurotransmitters, and serves as a prime target for drug discovery.
Pradeep Paudel, Su Hui Seong, Sangwook Wu, Suhyun Park, Hyun Ah Jung, Jae Sue Choi   +5 more
doaj   +1 more source

Author Correction: Inhibitory effects of dopamine receptor D(1) agonist on mammary tumor and bone metastasis [PDF]

, 2022
This corrects the article "Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis" in volume 7, 45686.
Gan, Liangying, Minami, Kazumasa, Na, Sungsoo, Chen, Andy, Li, Bai‑Yan, Li, Jiliang, Yokota, Hiroki, Liu, Shengzhi, Wan, Qiaoqiao, Liu, Yang, Matsuura, Nariaki, Nakshatri, Harikrishna, Yin, Yukun, Koizumi, Masahiko, Li, Bai-Yan, Xu, Aihua   +15 more
core   +1 more source

Tumor expression of dopamine receptor and prolactin is associated with acute dopamine agonist response in acromegaly

Frontiers in Endocrinology
ObjectivesIn acromegaly, primary treatment is usually pituitary surgery. Remission rates are approximately 50% with pituitary tumor size and invasiveness playing important roles. Medical therapy is the secondary treatment for many patients. Yet, dopamine
Shahriar Atai, Shahriar Atai, Merisa Abusdal, Merisa Abusdal, Merisa Abusdal, Maren Ileby Wessel, Maren Ileby Wessel, Maren Ileby Wessel, Olivera Casar-Borota, Olivera Casar-Borota, Kristin Astrid Øystese, Jacob Winther, Jacob Winther, Jens Bollerslev, Ansgar Heck   +14 more
doaj   +1 more source

Dopamine agonist–resistant prolactinomas

, 2011
The authors' object in this paper was to review the definition, epidemiology, biology, resistance mechanisms, and treatment options for dopamine agonist–resistant prolactinomas (DARPs).
Michael C. Oh, Manish K. Aghi
core   +1 more source

Resistant prolactinoma: Is it monoclonal or polyclonal?

Indian Journal of Endocrinology and Metabolism, 2013
Prolactinomas are solitary benign neoplasms and resistance to dopamine agonists occur in a small percentage of prolactinomas. Multiple pituitary adenomas are reported in less than 1% of pituitary adenomas and rarely result in resistant prolactinoma.
K. V. S. Hari Kumar, Pitambar Prusty
doaj   +1 more source

Does Intravitreal Dopamine Agonist and Antagonist Administration Have Effects on the Brain? An Experimental Study in Rats

, 2022
Objective: There might be dopaminergic connections between the retina and the brain. In this context, the study was aimed to investigate the possible interaction between the retina and basal ganglia through the dopaminergic system. Materials and Methods:
Ates, Irem, Koçak, Mehmet Nuri, Ates, Orhan, Okkay, Ufuk, Hacımuftuoglu, Ahmet, Ahmet Hacımuftuoglu, Nuri Kocak, Mehmet, Erdal Tekin, Irem Ates, Mehmet Nuri Kocak, Ahmet Hacimuftuoglu, Onur Ceylan, Tekin, Erdal, Ceylan, Onur, Orhan Ates, Ufuk Okkay   +15 more
core   +1 more source